ChromoCure, Inc. (KKUR)

ChromoCure Statistics

Total Valuation

ChromoCure has a market cap or net worth of 14,999.

Market Cap	14,999
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ChromoCure has 15.00 billion shares outstanding.

Current Share Class	15.00B
Shares Outstanding	15.00B
Shares Change (YoY)	n/a
Shares Change (QoQ)	+15.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.00%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.03
P/TBV Ratio	n/a
P/FCF Ratio	0.75
P/OCF Ratio	0.09
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	2.05
Debt / EBITDA	n/a
Debt / FCF	54.20
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-8.06%
Return on Invested Capital (ROIC)	-8.98%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-1,472
Employee Count	100
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	23.99
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	0.00
Relative Strength Index (RSI)	47.73
Average Volume (20 Days)	3,769,061

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	182.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-125,920
Pretax Income	-147,242
Net Income	-147,242
EBITDA	-121,722
EBIT	-125,920
Earnings Per Share (EPS)	-0.00

Balance Sheet

The company has 111,699 in cash and 1.08 million in debt, giving a net cash position of -970,375 or -0.00 per share.

Cash & Cash Equivalents	111,699
Total Debt	1.08M
Net Cash	-970,375
Net Cash Per Share	-0.00
Equity (Book Value)	528,160
Book Value Per Share	0.00
Working Capital	111,699

Cash Flow

In the last 12 months, operating cash flow was 173,656 and capital expenditures -153,693, giving a free cash flow of 19,963.

Operating Cash Flow	173,656
Capital Expenditures	-153,693
Free Cash Flow	19,963
FCF Per Share	0.00

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ChromoCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-692,579.13%
Shareholder Yield	n/a
Earnings Yield	-981.68%
FCF Yield	133.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 5, 2007. It was a reverse split with a ratio of 0.0033333333.

Last Split Date	Apr 5, 2007
Split Type	Reverse
Split Ratio	0.0033333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a